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Abstract 
A new, widely applicable process that combines reaction and separation in a single 
unit operation is described. The process, size-exclusion reaction chromatography 
(SERC), simultaneously allows control of the extent of reactions in which molecular 
size is altered and the separation of products and reactants. In SERC, a moving 
reaction zone is formed by injection of reactants onto a size-exclusion 
chromatography column. Reactants and products are partitioned differently within the 
mobile phase, resulting in different linear flow rates through the column. The products 
are therefore removed selectively from the reaction zone, minimising their residence 
time in the reaction zone and allowing their separation in the downstream section of 
the column. For reactions such as protein PEGylation, in which successive addition of 
PEG groups to the protein results in significant molecular size increases, SERC 
potentially offers a method by which a dominant final PEGylated protein size can be 
produced at high yield. The SERC PEGylation of two model proteins, α-lactalbumin 
and β-lactoglobulin, is demonstrated and results show that simultaneous reaction and 
separation was obtained. 
 
 
Introduction 
The circulation half-lives of small therapeutic proteins (<20 kDa) can be dramatically 
improved by increasing their molecular size through the covalent attachment of one or 
more polyethylene glycol (PEG) groups (Cunningham-Rundles et al. 1992; Francis et 
al. 1998; Gombotz and Pettit 2000). The attachment of PEG groups not only prevents 
early glomerular (kidney) filtration (Fung et al. 1997) but the water of hydration 
surrounding each PEG group moves constantly and is thought to slow immunological 
attack via steric hindrance (Abuchowski et al. 1977). Increasing the circulation half-
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life of a therapeutic protein has the dual benefits of increasing its overall efficacy and 
reducing the required frequency of dosage. The latter aspect can be an important 
factor in reducing patient discomfort and increasing product acceptability; particularly 
for treatments requiring repeated intravenous or sub-cutaneous administration. 
 
Various PEGylation chemistries have been described, usually involving reactions 
between activated forms of PEG and the N-terminal amine and lysine groups of the 
protein (Fisher et al. 1995; Fung et al. 1997). In standard methods, the native protein 
is mixed with activated PEG for a specified time and the extent of reaction is 
controlled largely by the reaction temperature and pH. Mono-PEGylated protein 
molecules are formed initially and residual active sites subsequently react to form di-
PEGylated molecules, and so on. The result is a distribution of products that differ 
both in the number of PEG groups attached and probably their attachment positions.  
 
This sequence of reactions poses serious problems. For example, controlling the 
reaction time to maximise the production of a tri-PEGylated product results in a 
mixture containing six protein species: native protein, 1-, 2-, 3-, 4- and 5-PEGylated 
proteins; plus unreacted activated PEG and reaction end-products. Not only is there a 
poor product yield but also heterogeneity of this kind is unacceptable in a therapeutic 
protein so downstream processing is necessary to obtain a homogeneous end product. 
Downstream processing is difficult because the physicochemical properties of the 
PEGylated protein species are very similar, apart from differences in their effective 
molecular size, and each step required for downstream processing decreases overall 
yield. 
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The low yields from PEGylation and the need for downstream processing represent 
significant costs for the PEGylated product over and above its native form. Given that 
the native therapeutic protein (generally a recombinant protein) must be purified to 
homogeneity prior to PEGylation, the overall production cost of the PEGylated 
protein is likely to be very high, offsetting the potential benefits of PEGylation. 
 
In this paper, a new reaction method, size-exclusion reaction chromatography 
(SERC), is described, which combines control of the PEGylation reaction with 
simultaneous purification of the products. In size-exclusion chromatography, 
molecular species are partitioned within the mobile phase according to their molecular 
sizes and shapes and the pore size distribution of the stationary phase. Because 
different molecular species are contained within differing total mobile phase volumes 
they migrate through a packed column at different rates. SERC utilizes a moving 
reaction zone within a size-exclusion chromatography column to control the time of 
contact between reactants, to selectively remove products from the reaction zone and 
to selectively inhibit reactions based on molecular size.  
 
A short pulse of activated PEG is injected onto a size-exclusion column running at a 
constant volumetric flow rate. A subsequent pulse of native protein will eventually 
catch up to the slower-moving PEG pulse, forming a moving reaction zone that exists 
for as long as the two reactant pulses occupy the same axial position in the column. 
The addition of a 5000 Da PEG group adds significantly more than 5000 Da to the 
effective molecular weight of the protein, as measured by size-exclusion 
chromatography, due to the water of hydration associated with the PEG group. For 
example, it is shown in this paper that the addition of a single 5000 Da PEG group to 
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a 35.8 kDa protein results in a mono-PEGylated protein with an apparent molecular 
weight in excess of 100 kDa as measured by size exclusion in a column calibrated 
using protein standards. Thus the PEGylated product is partitioned differently from 
either of the two reactants. If the size-exclusion medium is chosen carefully, the 
PEGylated product will be partitioned into the void space and so will move relatively 
quickly out of the reaction zone. Additional column length downstream of the 
reaction zone allows separation of the reactants and products. By choosing 
appropriate reactant pulse volumes, reactant concentrations and volumetric flow rates, 
a great deal of control can be exercised over the reaction conditions and the length of 
the subsequent separation zone. 
 
Results of SERC PEGylation of two model proteins, α-lactalbumin and β-
lactoglobulin, are presented in this paper. Expectations were that the large molecular 
weight products of PEGylation would be partitioned into the void volume of the size-
exclusion column and therefore be selectively removed from the (slower-moving) 
reaction zone, thus minimising multiple PEGylation reactions. Additionally, the size-
exclusion medium may also act to prevent the formation of a product larger than the 
pore size in which the reactants are located. It is surmised that this latter effect has far 
greater potential for controlling such reactions, through appropriate choice of the size-
exclusion media pore size, than differences in migration rates through the column. 
 
Materials & Methods 
Reagents 
Activated PEG reagent, mPEG succinimidyl propionate (mPEG-SPA), molecular 
weight 5000 Da, was purchased from Shearwater Corporation, Alabama. α-
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lactalbumin, (14,200 Da) and β-lactoglobulin dimer (35,800 Da) were purchased from 
Sigma-Aldrich Corporation, Australia. Gel filtration chromatograms of the two 
proteins and mPEG-SPA are shown in figure 1. A minor amount of α-lactalbumin is 
evident in the β-lactoglobulin material but otherwise the two proteins are sufficiently 
pure for PEGylation studies. 
 
All solutions were made up in 20 mM Tris-HCl buffer at pH 7.5. 
 
Batch PEGylation 
Batch PEGylation was carried out with each protein individually to follow the 
reaction progress in the absence of the size-exclusion medium. 10 mL of 20 mg/mL 
mPEG-SPA solution was added to 10 mL of 20 mg/mL native protein and stirred in 
an open 25 mL beaker at room temperature. One sample (approx. 1 mL) was 
withdrawn immediately after mixing the reactants and further samples were taken at 
10-minute intervals for 1 hour. Samples were placed into vials and acidified with one 
drop of 1N HCl to stop the reaction. 
 
SERC PEGylation 
SERC PEGylation of each protein was carried out to determine the elution profile 
from the size-exclusion column and to compare the overall product profiles with the 
corresponding batch PEGylation results. A HiLoad 16/60 Superdex 75 pg size-
exclusion column (Amersham Pharmacia Biotech, Uppsala, Sweden) was connected 
to an AKTAexplorer 10XT liquid chromatography system (Amersham Pharmacia 
Biotech, Uppsala, Sweden) and equilibrated with two column volumes of 20 mM 
Tris-HCl at pH 7.5. For α-lactalbumin PEGylation a specified volume of native 
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protein (10 mg/mL) was injected onto the column, followed immediately by an equal 
volume of mPEG-SPA (10 mg/mL), and vice versa for β-lactoglobulin PEGylation. 
UV absorbance was read at 280 nm. 5 mL fractions were collected continuously from 
the outlet stream after an initial 40 mL of buffer (i.e. slightly less than the void 
volume of the column) had passed through the column. 1 mL samples of each fraction 
was withdrawn by pipette and placed into auto sampler vials for size-exclusion 
analysis. The remaining portions of those fractions that contained proteins (identified 
from previous runs) were pooled and a sample of the pool was taken for size-
exclusion analysis. 
 
The distribution coefficients in the SERC column, Kav, were determined using 
standard methods (APBiotech ) to be 0.3500, 0.1768 and 0.2175 for α-lactalbumin, β-
lactoglobulin and mPEG-SPA, respectively. PEGylated proteins were assumed to be 
partitioned into the void volume, with a Kav value of 0. Reactant injection volumes 
and flow rates were then set to give estimated reaction zone residence times (i.e. the 
times for which the reactants overlapped in the column) by assuming that each 
reactant progressed through the column at a constant velocity, related to its Kav value.  
 
Analysis 
40 μL samples were injected onto a Superdex 200 HR10/30 size-exclusion column  
(Amersham Pharmacia Biotech, Uppsala, Sweden) connected to an AKTAexplorer 
10XT system (Amersham Pharmacia Biotech, Uppsala, Sweden) using an 
Autosampler A900, running phosphate buffered saline at 0.5 mL/min. The size-
exclusion column was first calibrated using standard protein molecular weight 
markers (Amersham Pharmacia Biotech, Uppsala, Sweden) in the range 1 x 104 – 1 x 
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106 Da and using standard PEG molecular weight markers (Phenomenex) in the range 
3 x 103 to 7.2 x 104 Da (figure 2). UV absorbance was read at 280 nm and the 
molecular weight profiles of samples recorded. Individual samples of α-lactalbumin 
and β-lactoglobulin (dimer) had retention volumes consistent with their native 
molecular weights according to the protein standard curve, while mPEG-SPA had a 
retention volume consistent with that expected from the PEG standard curve (figure 
1), corresponding to an equivalent protein molecular weight of 22 kDa. 
 
Results 
Batch PEGylation 
Figures 3 and 4 show gel filtration chromatograms for the products of batch 
PEGylation of α-lactalbumin and β-lactoglobulin, respectively.  
 
In each case there is a shift in the peak areas with time, showing a reduction in the 
native protein peak, an initial increase and then decrease in the mono-PEGylated 
protein peak, and corresponding increases in the multiple-PEGylated species with 
time. 
 
SERC PEGylation 
Figures 5 and 6 show the elution profiles obtained from the SERC process for α-
lactalbumin and β-lactoglobulin, respectively. Gel filtration analyses of the fractions 
collected are given in Figures 7 and 8. These show that the larger molecular weight 
species were eluted early and that there was good separation of the protein species 
from the residual mPEG-SPA and other low molecular weight reaction products, 
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especially for α-lactalbumin PEGylation. Thus simultaneous reaction and separation 
was achieved.  
 
Figures 9 and 10 show the pooled protein fractions eluted from the SERC process for 
α-lactalbumin and β-lactoglobulin, respectively. Comparison of these figures with 
batch PEGylation (figures 3 and 4) shows that SERC PEGylation (3 hours)  resulted 
in a higher ratio of mono-PEGylated product than the corresponding batch processes 
(1 hour). 
 
 
Discussion 
The results show that protein PEGylation can be carried out in a size-exclusion 
column and that reactants and products are separated in the process. Size-exclusion is 
a logical choice for the purification of PEGylated proteins and this combination of 
reaction and separation in a single unit operation should reduce capital costs and 
eliminate the need for handling and conditioning between reaction and separation 
steps. 
 
Of interest in figures 3 and 4, are the peaks seen at a retention volume of 
approximately 20 mL in most curves, which increase as the reaction proceeds. The 
chromatograms for the samples taken immediately after mixing the reactants (< 1 
min) seem to have broad peaks, with relatively small peaks seen with a 20 mL 
retention volume. This suggests that the mPEG-SPA is quickly associated with the 
protein species and is then released relatively slowly. This conjecture is confirmed by 
the very broad elution profiles of this component during SERC runs (figures 5 and 6). 
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Also a small peak containing low molecular weight components occurs in figures 3 
and 4 at approximately the total column volume (23.5 mL) at the beginning of the 
reactions but is not present at later times. This peak has not been identified but is 
possibly the result of acidifying free activated PEG with HCl. 
 
Kav values were calculated for the reaction products from their retention volumes on 
the analytical column. The standard curves in figure 1 show that proteins and PEG’s 
behave differently in the size exclusion column. Using the PEG standard curve in 
figure 1 to determine molecular weights of PEGylated proteins from their Kav values 
results in significantly underestimated molecular weights, although there is a linear 
relationship (correlation coefficient, R2 > 0.99) between the number of PEG groups 
attached and the molecular weight estimated by this means (figure 11). Each 
additional 5 kDa PEG group attached consistently adds 7 kDa in effective molecular 
weight to the PEGylated product of both proteins. This, along with the step-wise 
changes in analytical size exclusion elution volumes for the reaction products, is good 
circumstantial evidence for concluding that the number of PEG groups attached to the 
products has been correctly identified.  
 
Use of the protein standard curve in figure 1 significantly overestimated the molecular 
weight of the PEGylated proteins, with each additional PEG group adding between 50 
and 100 kDa (figure 11) to the apparent molecular weight. In contrast to the use of the 
PEG standard curve, the relationship between the number of PEG groups added and 
the increase in apparent molecular weight is not linear.  
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Despite the consistent 7 kDa increase in apparent molecular weight with each PEG 
group added to both proteins, it is clear that the actual molecular weights of the 
PEGylated proteins are not correctly estimated using PEG standards. The actual 
molecular weights of the PEGylated protein products identified by size exclusion 
were calculated from the known molecular weights of the native proteins and that of 
the activated PEG and these were then plotted in figure 1 against the Kav values 
calculated from their retention volumes. As might be expected, PEGylated proteins 
behave neither as proteins nor as PEG’s with respect to their size exclusion behaviour. 
There is a consistent trend for the size exclusion behaviour of both proteins to move 
progressively from the protein standard curve towards the PEG standard curve with 
each additional PEG group attached. 
 
Because PEG is transparent to UV light, it is reasonable to conclude that the UV 
absorbance of PEGylated species is due only to the protein part of each molecule and 
therefore an estimate of batch PEGylation reaction rates can be obtained from figures 
3 and 4. Figure 12 shows the change with time of the native protein peak areas as a 
percentage of the total protein peak areas in figures 3 and 4. Assuming the peak areas 
are directly proportional to the protein concentration, this indicates that α-lactalbumin 
reacts faster than β-lactoglobulin, though the difference is not particularly large. The 
initial concentration of each reactant in the batch reactions was 10 mg/mL. This 
corresponds to initial molar concentrations of 0.70, 0.28 and 2.0 μmol/mL of α-
lactalbumin, β-lactoglobulin and mPEG-SPA, respectively. However, it is not the 
total molar concentration of each protein but of each reactive site that is important. 
mPEG-SPA has one reactive site per molecule and this reacts with lysine groups and 
N-terminal amines. An examination of their 3D structures (Berman et al. 2000) shows 
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that α-lactalbumin has 4 lysine groups and the N-terminal amine group accessible at 
its surface, while the β-lactoglobulin monomer has 5 lysine groups accessible at the 
surface. All other lysine groups on both proteins and the N-terminal amine group of 
the β-lactoglobulin monomer are at least partially “buried” within the molecule so can 
be assumed to be inaccessible for PEGylation. β-lactoglobulin exists as a dimer at the 
pH used in this study, so assuming that the accessible lysine groups of each monomer 
are not obscured by the formation of the dimer, we can estimate that β-lactoglobulin 
has 10 reactive sites per mole of dimer, while α-lactalbumin has 5 per mole of 
monomer. The initial concentrations of active sites are therefore 3.5, 2.8 and 2.0 
μmol/mL, for α-lactalbumin, β-lactoglobulin and mPEG-SPA, respectively. Thus, at 
least to a first approximation, the faster reaction rate of α-lactalbumin and the 
evidence of tri-PEGylated α-lactalbumin in figure 3 and the absence of tri-PEGylated 
β-lactoglobulin in figure 4 are consistent with the initial reactant concentrations. In 
both cases the limiting reactant was mPEG-SPA. Other factors may come into play 
such as the mobility of the proteins’ 3D structures and possible obscuration of nearby 
reactive sites by attached PEG groups. A more detailed analysis of the reaction 
kinetics is beyond the scope of this paper. 
 
The broadness of the residual PEG molecule peak, its early appearance and its shape 
(figures 5 and 6), suggests that residual PEG was carried along the column with the 
larger molecular weight species, supporting the conjecture above that PEG quickly 
becomes associated with the protein species but is released more slowly. Virtually all 
protein was eluted (with little residual PEG content) from the column by the end of 
the major peak in both cases. It is unclear why these residual PEG molecules are 
eventually released rather than being covalently bonded to the protein.  
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 The difference in the molecular weight profiles between SERC (figures 9 and 10) and 
batch (figures 3 and 4) PEGylation is consistent with the hypothesis that the larger, 
PEGylated molecules are partitioned into the void volume and move out of the 
reaction zone at a higher rate than the native protein, thereby reducing the probability 
that they will be involved in further PEGylation.  
 
Differences in the extent of reaction in SERC might be expected because of 
differences in the mobile phase partitioning of the two proteins i.e. β-lactoglobulin 
has a higher concentration in the void space than does α-lactalbumin and therefore a 
greater proportion is available for reaction. The mobile phase partition coefficient, Kd, 
is given by 
 
i
oe
d V
VVK −=  
where Vi is the volume of the mobile phase inside the gel which is available to very 
small molecules, Ve is the elution volume of the molecule of interest and Vo is the 
void volume of the size-exclusion column. Ve was measured for each protein, Vo was 
found from the retention volume of 2,000,000 molecular weight blue dextran (totally 
excluded from the gel pores), and Vi was found from the difference in elution volume 
between the blue dextran and a sample of NaCl (the latter measured using a 
conductivity peak). Kd values for α-lactalbumin and β-lactoglobulin were calculated 
to be 0.4781 and 0.3085, respectively. Using these Kd values, the initial 10 mg/mL α-
lactalbumin pulse is concentrated to 7.32 μmol/mL of active sites within the mobile 
phase of the SERC column, while β-lactoglobulin is concentrated to 9.08 μmol/mL of 
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active sites. If there were no steric hindrance effects by the pores then one might 
expect β-lactoglobulin to react about 24% faster than α-lactalbumin, based on the 
batch reaction results.  Figure 9 and 10 show a greater extent of PEGylation of β-
lactoglobulin than of α-lactalbumin by SERC, although the extent of reaction would 
also be a function of the length of time the reactants overlapped in the column and 
therefore of their relative Kav values. 
 
It should also be noted that mPEG-SPA hydrolyses in water, with an expected half-
life of about 30 to 45 minutes at the pH used in this study. A better choice of 
PEGylation reagent might be the more stable aldehyde or carbamate forms. 
  
This suggests a method for controlling reactions so as to obtain a high yield of a 
product with a specific molecular weight. A size-exclusion medium that separates the 
reactants poorly but that sharply excludes products equal to or larger than the target 
PEGylated protein size would maximise the reaction time but minimise the formation 
of over-PEGylated products. This means that one could design a size-exclusion 
medium specifically for the production of, say, a di-PEGylated protein. The by-
products and residual PEG species, etc could be separated from the di-PEGylated 
protein product by collecting fractions in the exit stream, producing a largely 
homogeneous product at high yield. This, in combination with a reduction in capital 
costs and eliminating handling between reaction and separation steps, has the 
potential to greatly improve process economics. 
 
The applicability of SERC is not restricted to protein PEGylation reactions but could 
potentially be used for any reaction that results in a change in molecular size, such as 
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those involving glycosylation, polymerisation, or cleavage reactions, fusion proteins, 
poly- or oligo-peptides, amino acids, carbohydrates, inclusion bodies, microbial cells, 
viral particles, etc. 
 
A number of useful avenues exist for further research. These include examining the 
effects of operating conditions on PEGylation reaction kinetics, the effect of pore size 
and pore-size distribution on the extent of reaction and the effect of the size-exclusion 
medium characteristics in combination with various PEGylation chemistries on 
PEGylation site specificity. 
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Figures 
Figure 1. Elution profiles of native α-lactalbumin, β-lactoglobulin and mPEG-SPA on 
a Superdex 200 HR 10/30 size-exclusion column. 
Figure 2. Calibration curves for Superdex 200 HR 10/30 size-exclusion column for 
protein standards and PEG standards. Measured Kav values are also shown for 
the products resulting from batch PEGylation of α-lactalbumin and β-
lactoglobulin, for which the corresponding molecular weights are calculated 
from the number of PEG groups assumed to have been attached to each native 
protein. 
Figure 3. The effect of reaction time on the apparent molecular weight of α-
lactalbumin for batch PEGylation. 
Figure 4. The effect of reaction time on the apparent molecular weight of β-
lactoglobulin for batch PEGylation. 
Figure 5. The elution profile for SERC PEGylation of α-lactalbumin (UV absorbance 
at 280 nm). 
Figure 6. The elution profile for SERC PEGylation of β-lactoglobulin (UV 
absorbance at 280 nm). 
Figure 7. Molecular weight profiles of fractions collected during SERC PEGylation of 
α-lactalbumin. Chromatograms are stacked to aid readability. Numbers refer 
to fractions in figure 5. 
Figure 8. Molecular weight profiles of fractions collected during SERC PEGylation of 
β-lactoglobulin. Chromatograms are stacked to aid readability. Numbers refer 
to fractions in figure 6. 
Figure 9. Molecular weight profiles of pooled protein fractions collected during SERC 
PEGylation of α-lactalbumin. 
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Figure 10. Molecular weight profiles of pooled protein fractions collected during 
SERC PEGylation of β-lactoglobulin. 
Figure 11. Dependence of the apparent protein molecular weight on the number of 
PEG groups attached. 
Figure 12. Rate of reactions for batch PEGylation of α-lactalbumin and β-
lactoglobulin. 
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